These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3258675)

  • 1. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
    Müller M; Lossick JG; Gorrell TE
    Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
    Lin PR; Shaio MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.
    Lossick JG; Müller M; Gorrell TE
    J Infect Dis; 1986 May; 153(5):948-55. PubMed ID: 3486237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro.
    Tachezy J; Kulda J; Tomková E
    Parasitology; 1993 Jan; 106 ( Pt 1)():31-7. PubMed ID: 8479798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three metronidazole-resistant strains of Trichomonas vaginalis from the United States.
    Müller M; Meingassner JG; Miller WA; Ledger WJ
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):808-12. PubMed ID: 7004190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.
    Kulda J; Vojtĕchovská M; Tachezy J; Demes P; Kunzová E
    Br J Vener Dis; 1982 Dec; 58(6):394-9. PubMed ID: 6983379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
    Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.
    Borchardt KA; Li Z; Zhang MZ; Shing H
    Genitourin Med; 1996 Apr; 72(2):132-5. PubMed ID: 8698362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Trichomonas vaginalis strains to metronidazole: response to treatment.
    Ralph ED; Darwish R; Austin TW; Smith EA; Pattison FL
    Sex Transm Dis; 1983; 10(3):119-22. PubMed ID: 6359490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
    Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
    J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
    Meingassner JG; Stockinger K
    Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
    Smith RF; Di Domenico A
    Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
    Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
    Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
    Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
    J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.